Débora Sartori Giaretta

Débora Sartori Giaretta

Auto-generated profile, based on publicly available information

Débora Sartori Giaretta

School of Medicine, Pontifical Catholic University of Rio Grande do Sul (PUCRS), Porto Alegre, Brazil

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 June 2026 in Transplantation Proceedings
Verified
Journal Article
Open access
DGDébora Sartori Giaretta
Débora Sartori Giaretta
HMHelena Dai Prá Maestri
Helena Dai Prá Maestri
PCPedro Henrique Zanella Catto
Pedro Henrique Zanella Catto
ASAlessandra Dalla Rosa Santini
Alessandra Dalla Rosa Santini
MTMoacir Alexandre Traesel
Moacir Alexandre Traesel
LKLeonardo Viliano Kroth
Leonardo Viliano Kroth
Kidney transplantation is the best therapeutic option for patients with end-stage kidney disease, providing longer survival and quality of life. This retrospective single-center study analyzed all kidney transplants performed at Hospital São Lucas da PUCRS between 1978 and 2023, categorizing patients into different eras according to the evolution of immunosuppressive protocols. A total of 1,920 transplants were performed, and patient survival at 1, 3, and 5 years was evaluated, which was estimated at 89.6%, 86%, and 82.8%, respectively, for living donors and 85%, 80.3%, and 76.2%, respectively, for deceased donors. The acute rejection rate decreased from 39.2% in the years 1987 to 1997 to 18.8% in the most recent era. The impact of the COVID-19 pandemic was significant, increasing mortality and temporarily reducing the transplant rate. The findings demonstrate improvements in patient and graft survival over the years, in line with advances in surgical and immunosuppressive techniques. However, challenges such as infections and chronic complications remain relevant. Future studies should focus on optimizing clinical management and mitigating the impacts of health crises on the transplant population.

19 December 2024
Verified
Book Chapter
Closed access
BTBibiana Thomé
Bibiana Thomé
LSLetícia Mariel König de Souza
Letícia Mariel König de Souza
DGDébora Sartori Giaretta
Débora Sartori Giaretta
A avaliação pré-transplante é um processo criterioso que envolve consultas médicas com o receptor com vistas à avaliação clínico-laboratorial para investigação de potenciais complicadores pré e pós-cirúrgicos. A seguir, revisaremos o processo de avaliação clínica para ingresso em lista de transplante renal, de acordo com o protocolo do Serviço de Nefrologia do Hospital São Lucas da PUC.

14 March 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
DGDébora Giaretta
Débora Giaretta
HMHelena Dai Prá Maestri
Helena Dai Prá Maestri
PCPedro Henrique Zanella Catto
Pedro Henrique Zanella Catto
ASAlessandra Dalla Rosa Santini
Alessandra Dalla Rosa Santini
MTMoacir Alexandre Traesel
Moacir Alexandre Traesel
LKLeonardo Viliano Kroth
Leonardo Viliano Kroth
Kidney transplantation is the best therapeutic option for patients with end-stage kidney disease, providing longer survival and quality of life. This retrospective single-center study analyzed all kidney transplants performed at Hospital São Lucas da PUCRS between 1978 and 2023, categorizing patients into different eras according to the evolution of immunosuppressive protocols. A total of 1,920 transplants were performed, and patient survival at 1, 3, and 5 years was evaluated, which was estimated at 89.6%, 86%, and 82.8% retrospectively for living donors and 85%, 80.3%, and 76.2% retrospectively for deceased donors. The acute rejection rate decreased from 39.2% in the years 1987-1997 to 18.8% in the most recent era. The impact of the COVID-19 pandemic was significant, increasing mortality and temporarily reducing the transplant rate. The findings demonstrate improvements in patient and graft survival over the years, in line with advances in surgical and immunosuppressive techniques. However, challenges such as infections and chronic complications remain relevant. Future studies should focus on optimizing clinical management and mitigating the impacts of health crises on the transplant population.